|
Clustera
|
Mono-infections
|
Double infections
|
Triple infections
|
|---|
| | |
+ III
|
+ IV
|
+ III + IV
|
|---|
|
Cluster II
|
7/56 (12.5%)
|
18/56 (32.2%)
|
5/56 (8.9%)
|
5/56 (8.9%)
|
|
G: 1/7 (14.3%
|
G: 1/7 (14.3%)
|
G: 0/7 (0%)
|
G: 0/7 (0%)
|
|
A: 2/15 (13.3%)
|
A: 1/15 (6.7%)
|
A: 4/15 (26.7%)
|
A: 1/15 (6.7%)
|
|
V: 4/34 (11.8%)
|
V: 16/34 (47.1%)
|
V: 1/34 (2.9%)
|
V: 4/34 (11.8%)
|
|
Cluster III
|
7/56 (12.5%)
| |
6/56 (10.7%)
| |
|
G: 0/7 (0%)
| |
G: 2/7 (28.6%)
| |
|
A: 3/15 (20%)
| |
A: 1/15 (6.7%)
| |
|
V: 4/34 (11.8%)
| |
V: 3/34 (8.8%)
| |
|
Cluster IV
|
8/56 (14.3%)
| | | |
|
G: 3/7 (42.8%)
| | | |
|
A: 3/15 (20%)
| | | |
|
V: 2/34 (5.%)
| | | |
|
Total
|
Mono-infections
|
Double infections
|
Mixed infections (double and triple)
|
|
22/56 (39.3%)
|
29/56 (51.8%)
|
34/56 (60.7%)
|
|
G: 4/7 (57.1%)
|
G: 3/7 (42.9%)
|
G: 3/7 (42.9%)
|
|
A: 8/15 (53.3%)
|
A: 6/15 (40%)
|
A: 7/15 (46.7%)
|
|
V: 10/34 (29.4%)
|
V: 20/34 (58.8%)
|
V: 24/34 (70.6%)
|
-
Abbreviations: G Gardouch, A Aurignac, V Villecartier
-
aCluster numbers as in [6]. In each case, the first line in bold characters corresponds to the three locations together, and the three following, to each location separately
